Correlation Between Speakeasy Cannabis and Medicure
Can any of the company-specific risk be diversified away by investing in both Speakeasy Cannabis and Medicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Speakeasy Cannabis and Medicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Speakeasy Cannabis Club and Medicure, you can compare the effects of market volatilities on Speakeasy Cannabis and Medicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Speakeasy Cannabis with a short position of Medicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Speakeasy Cannabis and Medicure.
Diversification Opportunities for Speakeasy Cannabis and Medicure
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Speakeasy and Medicure is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Speakeasy Cannabis Club and Medicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicure and Speakeasy Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Speakeasy Cannabis Club are associated (or correlated) with Medicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicure has no effect on the direction of Speakeasy Cannabis i.e., Speakeasy Cannabis and Medicure go up and down completely randomly.
Pair Corralation between Speakeasy Cannabis and Medicure
If you would invest 63.00 in Medicure on September 4, 2024 and sell it today you would earn a total of 7.00 from holding Medicure or generate 11.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.0% |
Values | Daily Returns |
Speakeasy Cannabis Club vs. Medicure
Performance |
Timeline |
Speakeasy Cannabis Club |
Medicure |
Speakeasy Cannabis and Medicure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Speakeasy Cannabis and Medicure
The main advantage of trading using opposite Speakeasy Cannabis and Medicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Speakeasy Cannabis position performs unexpectedly, Medicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicure will offset losses from the drop in Medicure's long position.Speakeasy Cannabis vs. Cann American Corp | Speakeasy Cannabis vs. Benchmark Botanics | Speakeasy Cannabis vs. Link Reservations |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements |